Amivantamab for the treatment of EGFR exon 20 insertion mutant non-small cell lung cancer
Author:
Affiliation:
1. Division of Molecular Pathology, The Institute of Cancer Research, Sutton, UK
Funder
Institute of Cancer Research
Publisher
Informa UK Limited
Subject
Pharmacology (medical),Oncology
Link
https://www.tandfonline.com/doi/pdf/10.1080/14737140.2022.2016397
Reference95 articles.
1. First-Line Crizotinib versus Chemotherapy in ALK-Positive Lung Cancer
2. Crizotinib in ROS1-Rearranged Non–Small-Cell Lung Cancer
3. Entrectinib in NTRK fusion-positive non-small cell lung cancer (NSCLC): Integrated analysis of patients (pts) enrolled in STARTRK-2, STARTRK-1 and ALKA-372-001
4. Dabrafenib plus trametinib in patients with previously untreated BRAFV600E-mutant metastatic non-small-cell lung cancer: an open-label, phase 2 trial
5. Efficacy of Selpercatinib in RET Fusion–Positive Non–Small-Cell Lung Cancer
Cited by 18 articles. 订阅此论文施引文献 订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献
1. Comparison of Clinicopathogenomic Features and Treatment Outcomes of EGFR and HER2 Exon 20 Insertion Mutations in Non–Small Cell Lung Cancer: Single-Institution Experience;Cancer Research and Treatment;2024-07-15
2. The Advent of Molecular Targeted Therapies Against Cancer. Toward Multi‐Targeting Drugs Through Materials Engineering: A Possible Future Scenario;Small Science;2024-05-28
3. Amivantamab: A Novel Advance in the Treatment of Non-small Cell Lung Cancer;Cureus;2024-05-22
4. BiSpec Pairwise AI: guiding the selection of bispecific antibody target combinations with pairwise learning and GPT augmentation;Journal of Cancer Research and Clinical Oncology;2024-05-07
5. Novel therapeutic strategies for rare mutations in non-small cell lung cancer;Scientific Reports;2024-05-05
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3